Byrne, Christopher J.
Inglis, Sarah K.
Radley, Andrew
Beer, Lewis J.
Pham, Minh D.
Allardice, Kate
Palmer, Nicki
Healy, Brendan
Doyle, Joseph S.
Dillon, John F.
Article History
Received: 6 December 2024
Accepted: 6 October 2025
First Online: 31 October 2025
Declarations
:
: Not applicable: this work did not require human or animal ethical approval.
: Not applicable: not participants were recruited to this work.
: CJB reports honoraria from the International Network for Health and Hepatitis in Drugs Users (INHSU) and research funding from the Scottish Society of Physicians (SSP) outside of the submitted work. SKI reports no competing interests. AR reports he has received research grants from Gilead, Bristol Myers Squibb, Abbvie and Roche and has received honorariums from Gilead and personal fees from Abbvie. LJB reports grants from NIHR outside the submitted work. MDP reports no competing interests. KA reports no competing interests. NP reports no competing interests. BH reports personal fees and other from Abbvie, personal fees and other from Gilead, outside the submitted work. JSD reports funding to his institution for investigator-initiated research from Gilead Sciences and Abbvie; and honoraria to his institution for educational events from AbbVie. JFD has received research grants and lecture honoraria from MSD, AbbVie and Gilead, outside of the submitted work.